ID   URE1_ENTAE              Reviewed;         567 AA.
AC   P18314;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   01-APR-2015, entry version 130.
DE   RecName: Full=Urease subunit alpha {ECO:0000255|HAMAP-Rule:MF_01953};
DE            EC=3.5.1.5 {ECO:0000255|HAMAP-Rule:MF_01953};
DE   AltName: Full=Urea amidohydrolase subunit alpha {ECO:0000255|HAMAP-Rule:MF_01953};
GN   Name=ureC {ECO:0000255|HAMAP-Rule:MF_01953};
OS   Enterobacter aerogenes (Aerobacter aerogenes).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Enterobacter.
OX   NCBI_TaxID=548;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CATALYTIC ACTIVITY.
RC   STRAIN=CG253;
RX   PubMed=2211515;
RA   Mulrooney S.B., Hausinger R.P.;
RT   "Sequence of the Klebsiella aerogenes urease genes and evidence for
RT   accessory proteins facilitating nickel incorporation.";
RL   J. Bacteriol. 172:5837-5843(1990).
RN   [2]
RP   COFACTOR.
RX   PubMed=1624427;
RA   Lee M.H., Mulrooney S.B., Renner M.J., Markowicz Y., Hausinger R.P.;
RT   "Klebsiella aerogenes urease gene cluster: sequence of ureD and
RT   demonstration that four accessory genes (ureD, ureE, ureF, and ureG)
RT   are involved in nickel metallocenter biosynthesis.";
RL   J. Bacteriol. 174:4324-4330(1992).
RN   [3]
RP   CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF CYS-319.
RX   PubMed=1400317;
RA   Martin P.R., Hausinger R.P.;
RT   "Site-directed mutagenesis of the active site cysteine in Klebsiella
RT   aerogenes urease.";
RL   J. Biol. Chem. 267:20024-20027(1992).
RN   [4]
RP   CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF HIS-134; HIS-136; HIS-219; HIS-246; HIS-320 AND
RP   HIS-320.
RX   PubMed=8318888; DOI=10.1002/pro.5560020616;
RA   Park I.-S., Hausinger R.P.;
RT   "Site-directed mutagenesis of Klebsiella aerogenes urease:
RT   identification of histidine residues that appear to function in nickel
RT   ligation, substrate binding, and catalysis.";
RL   Protein Sci. 2:1034-1041(1993).
RN   [5]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH UREA; UREB AND URED.
RX   PubMed=7909161; DOI=10.1073/pnas.91.8.3233;
RA   Park I.-S., Carr M.B., Hausinger R.P.;
RT   "In vitro activation of urease apoprotein and role of UreD as a
RT   chaperone required for nickel metallocenter assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3233-3237(1994).
RN   [6]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH UREA; UREB; URED; UREF AND
RP   UREG.
RX   PubMed=7721685;
RA   Park I.-S., Hausinger R.P.;
RT   "Evidence for the presence of urease apoprotein complexes containing
RT   UreD, UreF, and UreG in cells that are competent for in vivo enzyme
RT   activation.";
RL   J. Bacteriol. 177:1947-1951(1995).
RN   [7]
RP   CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=7855593; DOI=10.1126/science.7855593;
RA   Park I.-S., Hausinger R.P.;
RT   "Requirement of carbon dioxide for in vitro assembly of the urease
RT   nickel metallocenter.";
RL   Science 267:1156-1158(1995).
RN   [8]
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND INTERACTION WITH UREA;
RP   UREB; URED AND UREF.
RX   PubMed=8808930;
RA   Moncrief M.B.C., Hausinger R.P.;
RT   "Purification and activation properties of UreD-UreF-urease apoprotein
RT   complexes.";
RL   J. Bacteriol. 178:5417-5421(1996).
RN   [9]
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND INTERACTION WITH UREA;
RP   UREB; URED; UREF AND UREG.
RX   PubMed=10500143; DOI=10.1073/pnas.96.20.11140;
RA   Soriano A., Hausinger R.P.;
RT   "GTP-dependent activation of urease apoprotein in complex with the
RT   UreD, UreF, and UreG accessory proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11140-11144(1999).
RN   [10]
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND ACTIVATION OF THE
RP   APOPROTEIN BY UREE.
RX   PubMed=11015224; DOI=10.1021/bi001296o;
RA   Soriano A., Colpas G.J., Hausinger R.P.;
RT   "UreE stimulation of GTP-dependent urease activation in the UreD-UreF-
RT   UreG-urease apoprotein complex.";
RL   Biochemistry 39:12435-12440(2000).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11594743; DOI=10.1006/abbi.2001.2536;
RA   Mulrooney S.B., Zakharian T., Schaller R.A., Hausinger R.P.;
RT   "Dual effects of ionic strength on Klebsiella aerogenes urease: pH-
RT   dependent activation and inhibition.";
RL   Arch. Biochem. Biophys. 394:280-282(2001).
RN   [12]
RP   INTERACTION WITH UREA; UREB; URED AND UREF, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=14749331; DOI=10.1074/jbc.M312979200;
RA   Chang Z., Kuchar J., Hausinger R.P.;
RT   "Chemical cross-linking and mass spectrometric identification of sites
RT   of interaction for UreD, UreF, and urease.";
RL   J. Biol. Chem. 279:15305-15313(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH UREA; UREB AND
RP   NICKEL IONS, AND CARBAMYLATION AT LYS-217.
RX   PubMed=7754395; DOI=10.1126/science.7754395;
RA   Jabri E., Carr M.B., Hausinger R.P., Karplus P.A.;
RT   "The crystal structure of urease from Klebsiella aerogenes.";
RL   Science 268:998-1004(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF WILD-TYPE AND MUTANTS ALA-219
RP   AND ALA-320 IN COMPLEX WITH UREA; UREB AND NICKEL IONS, AND
RP   CARBAMYLATION AT LYS-217.
RX   PubMed=8718850; DOI=10.1021/bi960424z;
RA   Jabri E., Karplus P.A.;
RT   "Structures of the Klebsiella aerogenes urease apoenzyme and two
RT   active-site mutants.";
RL   Biochemistry 35:10616-10626(1996).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF MUTANT ALA-134 IN COMPLEX
RP   WITH UREA; UREB AND NICKEL IONS, MAGNETIC CIRCULAR DICHROISM,
RP   ABSORPTION SPECTROSCOPY, AND CARBAMYLATION AT LYS-217.
RX   PubMed=8702515; DOI=10.1074/jbc.271.31.18632;
RA   Park I.-S., Michel L.O., Pearson M.A., Jabri E., Karplus P.A.,
RA   Wang S., Dong J., Scott R.A., Koehler B.P., Johnson M.K.,
RA   Hausinger R.P.;
RT   "Characterization of the mononickel metallocenter in H134A mutant
RT   urease.";
RL   J. Biol. Chem. 271:18632-18637(1996).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF MUTANTS ALA/ASP/SER/TYR-319
RP   IN COMPLEX WITH UREA; UREB; NICKEL IONS AND ACETOHYDROXAMIC ACID.
RX   PubMed=9201965; DOI=10.1021/bi970514j;
RA   Pearson M.A., Michel L.O., Hausinger R.P., Karplus P.A.;
RT   "Structures of Cys319 variants and acetohydroxamate-inhibited
RT   Klebsiella aerogenes urease.";
RL   Biochemistry 36:8164-8172(1997).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF MUTANTS ALA/CYS/GLU-217 IN
RP   COMPLEX WITH UREA; UREB AND FORMATE, AND MUTAGENESIS OF LYS-217.
RX   PubMed=9558361; DOI=10.1021/bi980021u;
RA   Pearson M.A., Schaller R.A., Michel L.O., Karplus P.A.,
RA   Hausinger R.P.;
RT   "Chemical rescue of Klebsiella aerogenes urease variants lacking the
RT   carbamylated-lysine nickel ligand.";
RL   Biochemistry 37:6214-6220(1998).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH UREA; UREB AND
RP   MANGANESE IONS, ABSORPTION SPECTROSCOPY, AND MUTAGENESIS OF CYS-319.
RX   PubMed=10555581; DOI=10.1007/s007750050333;
RA   Yamaguchi K., Cosper N.J., Staalhandske C., Scott R.A., Pearson M.A.,
RA   Karplus P.A., Hausinger R.P.;
RT   "Characterization of metal-substituted Klebsiella aerogenes urease.";
RL   J. Biol. Inorg. Chem. 4:468-477(1999).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF WILD-TYPE AND MUTANTS
RP   ASN/GLN-219; ALA-221 AND ASN/GLN-320 IN COMPLEX WITH UREA; UREB AND
RP   NICKEL IONS, CARBAMYLATION AT LYS-217, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND MUTAGENESIS OF HIS-219; ASP-221; HIS-320 AND ARG-336.
RX   PubMed=10913264; DOI=10.1021/bi000613o;
RA   Pearson M.A., Park I.-S., Schaller R.A., Michel L.O., Karplus P.A.,
RA   Hausinger R.P.;
RT   "Kinetic and structural characterization of urease active site
RT   variants.";
RL   Biochemistry 39:8575-8584(2000).
CC   -!- CATALYTIC ACTIVITY: Urea + H(2)O = CO(2) + 2 NH(3).
CC       {ECO:0000255|HAMAP-Rule:MF_01953, ECO:0000269|PubMed:10500143,
CC       ECO:0000269|PubMed:11015224, ECO:0000269|PubMed:1400317,
CC       ECO:0000269|PubMed:2211515, ECO:0000269|PubMed:7721685,
CC       ECO:0000269|PubMed:7855593, ECO:0000269|PubMed:7909161,
CC       ECO:0000269|PubMed:8318888, ECO:0000269|PubMed:8808930}.
CC   -!- COFACTOR:
CC       Name=Ni cation; Xref=ChEBI:CHEBI:25516;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01953,
CC         ECO:0000269|PubMed:1400317, ECO:0000269|PubMed:1624427,
CC         ECO:0000269|PubMed:8318888};
CC       Note=Binds 2 nickel ions per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_01953, ECO:0000269|PubMed:1400317,
CC       ECO:0000269|PubMed:1624427, ECO:0000269|PubMed:8318888};
CC   -!- ENZYME REGULATION: The apoenzyme can be activated in vitro in the
CC       presence of nickel ions and carbon dioxide, which promotes
CC       carbamylation of Lys-217. {ECO:0000269|PubMed:10500143,
CC       ECO:0000269|PubMed:11015224, ECO:0000269|PubMed:7855593,
CC       ECO:0000269|PubMed:8808930}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.3 mM for urea {ECO:0000269|PubMed:10913264,
CC         ECO:0000269|PubMed:11594743, ECO:0000269|PubMed:1400317,
CC         ECO:0000269|PubMed:8318888};
CC         Vmax=1.9 mmol/min/mg enzyme {ECO:0000269|PubMed:10913264,
CC         ECO:0000269|PubMed:11594743, ECO:0000269|PubMed:1400317,
CC         ECO:0000269|PubMed:8318888};
CC       pH dependence:
CC         Optimum pH is 7.75. {ECO:0000269|PubMed:10913264,
CC         ECO:0000269|PubMed:11594743, ECO:0000269|PubMed:1400317,
CC         ECO:0000269|PubMed:8318888};
CC   -!- PATHWAY: Nitrogen metabolism; urea degradation; CO(2) and NH(3)
CC       from urea (urease route): step 1/1. {ECO:0000255|HAMAP-
CC       Rule:MF_01953}.
CC   -!- SUBUNIT: Heterotrimer of UreA (gamma), UreB (beta) and UreC
CC       (alpha) subunits. Three heterotrimers associate to form the active
CC       enzyme. The apoenzyme interacts with an accessory complex composed
CC       of UreD, UreF and UreG, which is required for the assembly of the
CC       nickel containing metallocenter of UreC. The UreE protein may also
CC       play a direct role as a metallochaperone in nickel transfer to the
CC       urease apoprotein. {ECO:0000255|HAMAP-Rule:MF_01953,
CC       ECO:0000269|PubMed:10500143, ECO:0000269|PubMed:10555581,
CC       ECO:0000269|PubMed:10913264, ECO:0000269|PubMed:14749331,
CC       ECO:0000269|PubMed:7721685, ECO:0000269|PubMed:7754395,
CC       ECO:0000269|PubMed:7909161, ECO:0000269|PubMed:8702515,
CC       ECO:0000269|PubMed:8718850, ECO:0000269|PubMed:8808930,
CC       ECO:0000269|PubMed:9201965, ECO:0000269|PubMed:9558361}.
CC   -!- INTERACTION:
CC       P18316:ureA; NbExp=11; IntAct=EBI-1028571, EBI-1028581;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01953}.
CC   -!- PTM: Carbamylation allows a single lysine to coordinate two nickel
CC       ions. {ECO:0000255|HAMAP-Rule:MF_01953,
CC       ECO:0000269|PubMed:10913264, ECO:0000269|PubMed:7754395,
CC       ECO:0000269|PubMed:8702515, ECO:0000269|PubMed:8718850}.
CC   -!- SIMILARITY: Belongs to the urease family. {ECO:0000255|HAMAP-
CC       Rule:MF_01953}.
CC   -!- SIMILARITY: Contains 1 urease domain. {ECO:0000255|HAMAP-
CC       Rule:MF_01953}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M36068; AAA25151.1; -; Genomic_DNA.
DR   PDB; 1A5K; X-ray; 2.20 A; C=2-567.
DR   PDB; 1A5L; X-ray; 2.20 A; C=2-567.
DR   PDB; 1A5M; X-ray; 2.00 A; C=2-567.
DR   PDB; 1A5N; X-ray; 2.40 A; C=2-567.
DR   PDB; 1A5O; X-ray; 2.50 A; C=2-567.
DR   PDB; 1EF2; X-ray; 2.50 A; A=2-567.
DR   PDB; 1EJR; X-ray; 2.00 A; C=1-567.
DR   PDB; 1EJS; X-ray; 2.00 A; C=1-567.
DR   PDB; 1EJT; X-ray; 2.00 A; C=1-567.
DR   PDB; 1EJU; X-ray; 2.00 A; C=1-567.
DR   PDB; 1EJV; X-ray; 2.40 A; C=1-567.
DR   PDB; 1EJW; X-ray; 1.90 A; C=1-567.
DR   PDB; 1EJX; X-ray; 1.60 A; C=1-567.
DR   PDB; 1FWA; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWB; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWC; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWD; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWE; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWF; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWG; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWH; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWI; X-ray; 2.00 A; C=1-567.
DR   PDB; 1FWJ; X-ray; 2.20 A; C=1-567.
DR   PDB; 1KRA; X-ray; 2.30 A; C=1-567.
DR   PDB; 1KRB; X-ray; 2.50 A; C=1-567.
DR   PDB; 1KRC; X-ray; 2.50 A; C=1-567.
DR   PDB; 2KAU; X-ray; 2.00 A; C=1-567.
DR   PDB; 4EP8; X-ray; 1.55 A; C=2-567.
DR   PDB; 4EPB; X-ray; 1.75 A; C=2-567.
DR   PDB; 4EPD; X-ray; 1.70 A; C=2-567.
DR   PDB; 4EPE; X-ray; 2.05 A; C=2-567.
DR   PDBsum; 1A5K; -.
DR   PDBsum; 1A5L; -.
DR   PDBsum; 1A5M; -.
DR   PDBsum; 1A5N; -.
DR   PDBsum; 1A5O; -.
DR   PDBsum; 1EF2; -.
DR   PDBsum; 1EJR; -.
DR   PDBsum; 1EJS; -.
DR   PDBsum; 1EJT; -.
DR   PDBsum; 1EJU; -.
DR   PDBsum; 1EJV; -.
DR   PDBsum; 1EJW; -.
DR   PDBsum; 1EJX; -.
DR   PDBsum; 1FWA; -.
DR   PDBsum; 1FWB; -.
DR   PDBsum; 1FWC; -.
DR   PDBsum; 1FWD; -.
DR   PDBsum; 1FWE; -.
DR   PDBsum; 1FWF; -.
DR   PDBsum; 1FWG; -.
DR   PDBsum; 1FWH; -.
DR   PDBsum; 1FWI; -.
DR   PDBsum; 1FWJ; -.
DR   PDBsum; 1KRA; -.
DR   PDBsum; 1KRB; -.
DR   PDBsum; 1KRC; -.
DR   PDBsum; 2KAU; -.
DR   PDBsum; 4EP8; -.
DR   PDBsum; 4EPB; -.
DR   PDBsum; 4EPD; -.
DR   PDBsum; 4EPE; -.
DR   ProteinModelPortal; P18314; -.
DR   SMR; P18314; 2-567.
DR   IntAct; P18314; 3.
DR   DrugBank; DB00551; Acetohydroxamic Acid.
DR   DrugBank; DB05265; Ecabet.
DR   MEROPS; M38.982; -.
DR   BRENDA; 3.5.1.5; 152.
DR   SABIO-RK; P18314; -.
DR   UniPathway; UPA00258; UER00370.
DR   EvolutionaryTrace; P18314; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016151; F:nickel cation binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0009039; F:urease activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0043419; P:urea catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.30.40.10; -; 1.
DR   HAMAP; MF_01953; Urease_alpha; 1.
DR   InterPro; IPR006680; Amidohydro_1.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR011612; Urease_alpha_N_dom.
DR   InterPro; IPR017950; Urease_AS.
DR   InterPro; IPR005848; Urease_asu.
DR   InterPro; IPR017951; Urease_asu_c.
DR   InterPro; IPR029754; Urease_Ni-bd.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   Pfam; PF00449; Urease_alpha; 1.
DR   PRINTS; PR01752; UREASE.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   TIGRFAMs; TIGR01792; urease_alph; 1.
DR   PROSITE; PS01120; UREASE_1; 1.
DR   PROSITE; PS00145; UREASE_2; 1.
DR   PROSITE; PS51368; UREASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Hydrolase; Metal-binding; Nickel.
FT   CHAIN         1    567       Urease subunit alpha.
FT                                /FTId=PRO_0000067543.
FT   DOMAIN      129    567       Urease. {ECO:0000255|HAMAP-
FT                                Rule:MF_01953}.
FT   ACT_SITE    320    320       Proton donor.
FT   METAL       134    134       Nickel 1; via tele nitrogen.
FT   METAL       136    136       Nickel 1; via tele nitrogen.
FT   METAL       217    217       Nickel 1; via carbamate group.
FT   METAL       217    217       Nickel 2; via carbamate group.
FT   METAL       246    246       Nickel 2; via pros nitrogen.
FT   METAL       272    272       Nickel 2; via tele nitrogen.
FT   METAL       360    360       Nickel 1.
FT   BINDING     219    219       Substrate.
FT   MOD_RES     217    217       N6-carboxylysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_01953,
FT                                ECO:0000269|PubMed:10913264,
FT                                ECO:0000269|PubMed:7754395,
FT                                ECO:0000269|PubMed:8702515,
FT                                ECO:0000269|PubMed:8718850}.
FT   MUTAGEN     134    134       H->A: Abrogates activity and reduces
FT                                binding to nickel ions.
FT                                {ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     136    136       H->A: Abrogates activity and reduces
FT                                binding to nickel ions.
FT                                {ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     217    217       K->A,C,E: Reduces activity 8000-fold and
FT                                abrogates binding to nickel ions.
FT                                {ECO:0000269|PubMed:9558361}.
FT   MUTAGEN     219    219       H->A: Reduces activity 500-fold and
FT                                increases KM 1000-fold. Resistant to
FT                                inactivation by diethylpyrocarbonate and
FT                                iodoacetamide.
FT                                {ECO:0000269|PubMed:10913264,
FT                                ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     219    219       H->N,Q: Increases KM 100-fold; optimum pH
FT                                is 6. {ECO:0000269|PubMed:10913264,
FT                                ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     221    221       D->A: Reduces activity 1000-fold and
FT                                increases KM 10-fold.
FT                                {ECO:0000269|PubMed:10913264}.
FT   MUTAGEN     221    221       D->N: Reduces activity 50-fold.
FT                                {ECO:0000269|PubMed:10913264}.
FT   MUTAGEN     246    246       H->A: Abrogates activity and reduces
FT                                binding to nickel ions.
FT                                {ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     312    312       H->A: Enhances thermal stability above 50
FT                                degrees Celsius.
FT   MUTAGEN     319    319       C->A: Reduces activity 2-fold, but
FT                                increases KM only 1.7-fold; optimum pH is
FT                                6.7. Reduces binding of nickel ions.
FT                                Resistant to inactivation by
FT                                iodoacetamide.
FT                                {ECO:0000269|PubMed:10555581,
FT                                ECO:0000269|PubMed:1400317}.
FT   MUTAGEN     319    319       C->D: Reduces activity 20-fold, but
FT                                increases KM only 1.9-fold; optimum pH is
FT                                5.2. Reduces binding of nickel ions.
FT                                Resistant to inactivation by
FT                                iodoacetamide.
FT                                {ECO:0000269|PubMed:10555581,
FT                                ECO:0000269|PubMed:1400317}.
FT   MUTAGEN     319    319       C->S: Reduces activity 3000-fold, but
FT                                increases KM only 3.9-fold; optimum pH is
FT                                5.2. Reduces binding of nickel ions.
FT                                Resistant to inactivation by
FT                                iodoacetamide.
FT                                {ECO:0000269|PubMed:10555581,
FT                                ECO:0000269|PubMed:1400317}.
FT   MUTAGEN     319    319       C->Y: Abrogates activity.
FT                                {ECO:0000269|PubMed:10555581,
FT                                ECO:0000269|PubMed:1400317}.
FT   MUTAGEN     320    320       H->A: Reduces activity 100000-fold, but
FT                                increases KM only 3-fold; optimum pH is
FT                                6.75. Resistant to inactivation by
FT                                diethylpyrocarbonate and iodoacetamide.
FT                                {ECO:0000269|PubMed:10913264,
FT                                ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     320    320       H->N,Q: Reduces activity 100000-fold, but
FT                                increases KM only 3-fold.
FT                                {ECO:0000269|PubMed:10913264,
FT                                ECO:0000269|PubMed:8318888}.
FT   MUTAGEN     336    336       R->Q: Reduces activity 10000-fold, but
FT                                has no effect on KM.
FT                                {ECO:0000269|PubMed:10913264}.
FT   STRAND        3      5       {ECO:0000244|PDB:4EP8}.
FT   HELIX         6     13       {ECO:0000244|PDB:4EP8}.
FT   STRAND       20     22       {ECO:0000244|PDB:4EP8}.
FT   STRAND       29     31       {ECO:0000244|PDB:4EP8}.
FT   STRAND       50     53       {ECO:0000244|PDB:4EP8}.
FT   TURN         54     56       {ECO:0000244|PDB:4EP8}.
FT   HELIX        62     64       {ECO:0000244|PDB:4EP8}.
FT   STRAND       67     77       {ECO:0000244|PDB:4EP8}.
FT   STRAND       80     89       {ECO:0000244|PDB:4EP8}.
FT   STRAND       92     97       {ECO:0000244|PDB:4EP8}.
FT   TURN        102    104       {ECO:0000244|PDB:4EP8}.
FT   STRAND      105    107       {ECO:0000244|PDB:4EPD}.
FT   STRAND      109    111       {ECO:0000244|PDB:4EPB}.
FT   STRAND      117    120       {ECO:0000244|PDB:4EP8}.
FT   STRAND      125    128       {ECO:0000244|PDB:4EP8}.
FT   STRAND      130    136       {ECO:0000244|PDB:4EP8}.
FT   HELIX       142    149       {ECO:0000244|PDB:4EP8}.
FT   STRAND      151    157       {ECO:0000244|PDB:4EP8}.
FT   STRAND      159    162       {ECO:0000244|PDB:4EP8}.
FT   HELIX       163    167       {ECO:0000244|PDB:4EP8}.
FT   HELIX       173    184       {ECO:0000244|PDB:4EP8}.
FT   STRAND      187    196       {ECO:0000244|PDB:4EP8}.
FT   HELIX       202    211       {ECO:0000244|PDB:4EP8}.
FT   STRAND      214    219       {ECO:0000244|PDB:4EP8}.
FT   HELIX       220    222       {ECO:0000244|PDB:4EP8}.
FT   HELIX       226    239       {ECO:0000244|PDB:4EP8}.
FT   STRAND      242    246       {ECO:0000244|PDB:4EP8}.
FT   HELIX       256    263       {ECO:0000244|PDB:4EP8}.
FT   STRAND      268    270       {ECO:0000244|PDB:4EP8}.
FT   TURN        271    274       {ECO:0000244|PDB:4EP8}.
FT   STRAND      278    280       {ECO:0000244|PDB:4EP8}.
FT   TURN        281    283       {ECO:0000244|PDB:4EP8}.
FT   HELIX       284    289       {ECO:0000244|PDB:4EP8}.
FT   STRAND      293    297       {ECO:0000244|PDB:4EP8}.
FT   HELIX       299    301       {ECO:0000244|PDB:4EPB}.
FT   STRAND      305    307       {ECO:0000244|PDB:1KRA}.
FT   HELIX       308    320       {ECO:0000244|PDB:4EP8}.
FT   STRAND      324    326       {ECO:0000244|PDB:1EJW}.
FT   HELIX       327    336       {ECO:0000244|PDB:4EP8}.
FT   HELIX       339    350       {ECO:0000244|PDB:4EP8}.
FT   STRAND      356    358       {ECO:0000244|PDB:1EJX}.
FT   STRAND      363    365       {ECO:0000244|PDB:4EP8}.
FT   HELIX       370    385       {ECO:0000244|PDB:4EP8}.
FT   STRAND      393    395       {ECO:0000244|PDB:4EP8}.
FT   HELIX       397    404       {ECO:0000244|PDB:4EP8}.
FT   HELIX       405    407       {ECO:0000244|PDB:4EP8}.
FT   HELIX       409    414       {ECO:0000244|PDB:4EP8}.
FT   TURN        418    420       {ECO:0000244|PDB:4EP8}.
FT   STRAND      421    424       {ECO:0000244|PDB:4EP8}.
FT   STRAND      432    435       {ECO:0000244|PDB:4EP8}.
FT   HELIX       437    439       {ECO:0000244|PDB:4EP8}.
FT   TURN        440    442       {ECO:0000244|PDB:4EP8}.
FT   STRAND      445    449       {ECO:0000244|PDB:4EP8}.
FT   STRAND      452    458       {ECO:0000244|PDB:4EP8}.
FT   STRAND      463    466       {ECO:0000244|PDB:4EP8}.
FT   STRAND      472    475       {ECO:0000244|PDB:4EP8}.
FT   HELIX       477    479       {ECO:0000244|PDB:4EP8}.
FT   HELIX       481    487       {ECO:0000244|PDB:4EP8}.
FT   STRAND      489    492       {ECO:0000244|PDB:4EP8}.
FT   HELIX       494    498       {ECO:0000244|PDB:4EP8}.
FT   HELIX       501    504       {ECO:0000244|PDB:4EP8}.
FT   STRAND      509    513       {ECO:0000244|PDB:4EP8}.
FT   TURN        517    519       {ECO:0000244|PDB:4EP8}.
FT   HELIX       522    524       {ECO:0000244|PDB:4EP8}.
FT   STRAND      534    536       {ECO:0000244|PDB:4EP8}.
FT   TURN        538    540       {ECO:0000244|PDB:4EP8}.
FT   STRAND      543    545       {ECO:0000244|PDB:4EP8}.
FT   STRAND      548    550       {ECO:0000244|PDB:1FWI}.
FT   STRAND      555    557       {ECO:0000244|PDB:4EP8}.
FT   STRAND      559    561       {ECO:0000244|PDB:4EP8}.
FT   TURN        562    564       {ECO:0000244|PDB:4EP8}.
SQ   SEQUENCE   567 AA;  60305 MW;  2ECF3C4268A2E2C7 CRC64;
     MSNISRQAYA DMFGPTVGDK VRLADTELWI EVEDDLTTYG EEVKFGGGKV IRDGMGQGQM
     LAADCVDLVL TNALIVDHWG IVKADIGVKD GRIFAIGKAG NPDIQPNVTI PIGAATEVIA
     AEGKIVTAGG IDTHIHWICP QQAEEALVSG VTTMVGGGTG PAAGTHATTC TPGPWYISRM
     LQAADSLPVN IGLLGKGNVS QPDALREQVA AGVIGLKIHE DWGATPAAID CALTVADEMD
     IQVALHSDTL NESGFVEDTL AAIGGRTIHT FHTEGAGGGH APDIITACAH PNILPSSTNP
     TLPYTLNTID EHLDMLMVCH HLDPDIAEDV AFAESRIRRE TIAAEDVLHD LGAFSLTSSD
     SQAMGRVGEV ILRTWQVAHR MKVQRGALAE ETGDNDNFRV KRYIAKYTIN PALTHGIAHE
     VGSIEVGKLA DLVVWSPAFF GVKPATVIKG GMIAIAPMGD INASIPTPQP VHYRPMFGAL
     GSARHHCRLT FLSQAAAANG VAERLNLRSA IAVVKGCRTV QKADMVHNSL QPNITVDAQT
     YEVRVDGELI TSEPADVLPM AQRYFLF
//
